Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ke Si

Showing results (121-130 of 138) with videos related to

Pageof 14
Sort By:
Evidence-Based Complementary and Alternative Medicine : Ecam|October 10, 2018
(+)-Usnic Acid Inhibits Migration of c-KIT Positive Cells in Human Colorectal CancerWei Wu, Bing Hou, Changli Tang, et al.
Journal of Materials Chemistry. B|January 26, 2022
Correction: A biocompatible two-photon absorbing fluorescent mitochondrial probe for deep <i>in vivo</i> bioimagingLingmin Lin, Zewei He, Tianfang Zhang, et al.
Plant Physiology|June 16, 2026
Effector Fg34 Triggers TaHRC-R-Mediated Calcium Signaling to Bolster Fusarium Head Blight Resistance in WheatWang Long-Shen, Gong Da-Chun, Yang Zhi, et al.
Journal of Ethnopharmacology|March 26, 2017
Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathwaysChunliu Mi, Juan Ma, Ke Si Wang, et al.
Phytotherapy Research : PTR|October 19, 2017
Chelidonine inhibits TNF-α-induced inflammation by suppressing the NF-κB pathways in HCT116 cellsZhi Hong Zhang, Chunliu Mi, Ke Si Wang, et al.
International Journal of Molecular Medicine|December 13, 2012
Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibitionChang-Chun Niu, Chen Zhao, Zhen-Dong Yang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2024
Corrigendum to "The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy" Biomed. Pharmacother. 165 (2023) 114893Shuo Yuan, Ke-Si Wang, Huan Meng, et al.
Genomics, Proteomics & Bioinformatics|June 10, 2026
A Spatially Resolved Atlas of Alternative Polyadenylation Across 18 Human Tissues and 76 Disease StatesZehang Jiang, Zhuochao Min, Zhanying Wu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 23, 2023
The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapyShuo Yuan, Ke-Si Wang, Huan Meng, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 20, 2011
[The risk factors for chronic obstructive pulmonary disease in Xinjiang rural areas]Min Ling, Yan Rong, An-shuan Gou, et al.
Pageof 14

Showing results (121-130 of 138) with videos related to

Sort By:
Pageof 14
Evidence-Based Complementary and Alternative Medicine : Ecam|October 10, 2018
(+)-Usnic Acid Inhibits Migration of c-KIT Positive Cells in Human Colorectal CancerWei Wu, Bing Hou, Changli Tang, et al.
Journal of Materials Chemistry. B|January 26, 2022
Correction: A biocompatible two-photon absorbing fluorescent mitochondrial probe for deep <i>in vivo</i> bioimagingLingmin Lin, Zewei He, Tianfang Zhang, et al.
Plant Physiology|June 16, 2026
Effector Fg34 Triggers TaHRC-R-Mediated Calcium Signaling to Bolster Fusarium Head Blight Resistance in WheatWang Long-Shen, Gong Da-Chun, Yang Zhi, et al.
Journal of Ethnopharmacology|March 26, 2017
Imperatorin suppresses proliferation and angiogenesis of human colon cancer cell by targeting HIF-1α via the mTOR/p70S6K/4E-BP1 and MAPK pathwaysChunliu Mi, Juan Ma, Ke Si Wang, et al.
Phytotherapy Research : PTR|October 19, 2017
Chelidonine inhibits TNF-α-induced inflammation by suppressing the NF-κB pathways in HCT116 cellsZhi Hong Zhang, Chunliu Mi, Ke Si Wang, et al.
International Journal of Molecular Medicine|December 13, 2012
Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibitionChang-Chun Niu, Chen Zhao, Zhen-Dong Yang, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 9, 2024
Corrigendum to "The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapy" Biomed. Pharmacother. 165 (2023) 114893Shuo Yuan, Ke-Si Wang, Huan Meng, et al.
Genomics, Proteomics & Bioinformatics|June 10, 2026
A Spatially Resolved Atlas of Alternative Polyadenylation Across 18 Human Tissues and 76 Disease StatesZehang Jiang, Zhuochao Min, Zhanying Wu, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 23, 2023
The gut microbes in inflammatory bowel disease: Future novel target option for pharmacotherapyShuo Yuan, Ke-Si Wang, Huan Meng, et al.
Zhonghua Jie He He Hu Xi Za Zhi = Zhonghua Jiehe He Huxi Zazhi = Chinese Journal of Tuberculosis and Respiratory Diseases|December 20, 2011
[The risk factors for chronic obstructive pulmonary disease in Xinjiang rural areas]Min Ling, Yan Rong, An-shuan Gou, et al.
Pageof 14